SJS Investment Consulting’s Pacific Biosciences PACB Stock Holding History

SJS Investment Consulting’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.92K	Buy	1,144 +1,094	+2,188%	+$1.59K	﹤0.01%	1793
2026 Q1	$66	Buy	+50	New	+$89	﹤0.01%	2216
2024 Q2	–	Sell	-6	Closed	-$23	–	1697
2024 Q1	$23	Sell	6 -3	-33%	-$18	﹤0.01%	1634
2023 Q4	$89	Buy	9 +3	+50%	+$25	﹤0.01%	1561
2023 Q3	$51	Sell	6 -3	-33%	-$34	﹤0.01%	1587
2023 Q2	$120	Buy	9 +3	+50%	+$36	﹤0.01%	1488
2023 Q1	$70	Buy	+6	New	+$60	﹤0.01%	1489

Other funds holding PACB

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

BLAM

Bourne Lent Asset Management Pawling, New York $289M AUM 30.86% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Advisornet Financial Minnetonka, Minnesota $2.19B AUM 21.28% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

KWM

Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return

BEI

Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return

KCPG

Kavar Capital Partners Group Leawood, Kansas $812M AUM 29.76% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SJS Investment Consulting's PACB Position: Q2 2026 in Review

SJS Investment Consulting increased its Pacific Biosciences (PACB) stake by 2,188% in Q2 2026, buying an estimated $1.59K and bringing the position to 1,144 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

SJS Investment Consulting first reported a position in PACB in Q1 2023 and has held it in 7 quarters since. 46 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

SJS Investment Consulting held 1,144 shares of Pacific Biosciences worth $1.92K as of Q2 2026.
SJS Investment Consulting bought 1,094 Pacific Biosciences shares in Q2 2026, an estimated $1.59K.
Pacific Biosciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1793 holding.
SJS Investment Consulting first reported a position in Pacific Biosciences in Q1 2023 and has held it in 7 quarters since.
46 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.